# The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial

> **NCT02885545** · PHASE4 · WITHDRAWN · sponsor: **Population Health Research Institute**

## Conditions studied

- Chronic Kidney Disease
- Acute Bleeding
- Cerebrovascular Stroke

## Interventions

- **DEVICE:** Watchman
- **DRUG:** Continued therapy with the prescribed oral anticoagulant

## Key facts

- **NCT ID:** NCT02885545
- **Lead sponsor:** Population Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-09
- **Primary completion:** 2018-03-05
- **Final completion:** 2018-03-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Failure to recruit any participants in more than one year of recruiting.
- **Last updated:** 2018-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02885545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02885545, "The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02885545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*